Vascular endothelial growth factor as a potential biomarker in systemic sclerosis: a systematic review and meta-analysis
IntroductionSystemic sclerosis (SSc), a chronic autoimmune condition, is characterized by microvascular dysfunction, ineffective angiogenesis, and fibrosis. The identification of robust biomarkers reflecting these processes may assist in clinical management and lead to the discovery of new therapies...
Saved in:
| Main Authors: | Angelo Zinellu, Arduino A. Mangoni |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-11-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1442913/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Endostatin as a biomarker of systemic sclerosis: insights from a systematic review and meta-analysis
by: Arduino A. Mangoni, et al.
Published: (2024-12-01) -
Evaluating the Predictive Value of the Dose-volume Parameters and Vascular Endothelial Growth Factor Expression on Rectal Toxicity in Prostate Cancer Patients
by: Marziyeh Mirzaeiyan, et al.
Published: (2024-12-01) -
Vascular endothelial growth factor facilitates the effects of telocytes on tumor cell proliferation and migration
by: Fujie Li, et al.
Published: (2024-11-01) -
Serum Vascular Endothelial Growth Factor in Pregnant Women with Different Types of Assisted Reproductive Techniques
by: Zainab Y. Ejam, et al.
Published: (2024-12-01) -
Vascular endothelial growth factor and endocan expression in adrenal cortical tumors and their relationship with histopathological prognostic parameters
by: Melia Karaköse, et al.
Published: (2024-08-01)